Keysight Technologies, Inc. (NYSE: KEYS) introduced a new portfolio of scale-up validation solutions designed to help ...
Jonathan Andrus, co-CEO of CRIO, explains how protocol-driven eSource templates and standardized data capture are improving consistency, oversight, and efficiency across clinical trial sites.
Regulators are modernizing their expectations, and it's become clear that validation can no longer function as a point-in-time event.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results